Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 11-jild 2-son (2026)
MYOSTEATOSIS IN METASTATIC GYNECOLOGIC CANCER: CURRENT STATE OF THE PROBLEM
ШАХАНОВА Шахноза Шавкатовна, ХОШИМОВ Баходир Бахромович
Annotatsiya
Myosteatosis, defined as fatty infiltration of skeletal muscle, is an important component of body composition disorders in oncology. In metastatic gynecologic cancers, this condition is frequently underestimated when relying on conventional anthropometric measures, despite its significant impact on treatment tolerance and prognosis. This review summarizes current evidence on the pathophysiological mechanisms of myosteatosis, its association with chemotherapy-related toxicity, and its influence on overall and progression-free survival. Computed tomography–derived muscle density is shown to be an independent prognostic factor of adverse oncologic outcomes, particularly in patients with preserved or increased body mass index. The integration of myosteatosis assessment into multifactorial risk stratification models may improve personalized management strategies for patients with metastatic gynecologic malignancies.
миостеатоз, онкогинекологический рак, метастазы, токсичность химиотерапии, выживаемость, компьютерная томографияmyosteatosis, gynecologic cancer, metastasis, chemotherapy toxicity, survival, computed tomographymiosteatoz, onkoginekologik rak, metastazlar, kimyoterapiya toksikligi, omon qolish, kompyuter tomografiya
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.